Under Armour: The 38% YTD Rally Gets Ahead of the Turnaround

Under Armour (UAA) has been one of the bigger rebound stories of the year, up 38% year-to-date from a 52-week low of $4.13. The stock is now trading at $6.91, and the chatter around a turnaround is loud enough to suggest the worst is over.

The rating is Hold. The valuation at roughly 0.6 times EV/sales provides a floor, but the business is still shrinking, still unprofitable, and the YTD rally has already priced in a fairly optimistic version of the recovery. The August 7 earnings report is the event that separates real inflection from bounce-back theater. Until then, the risk/reward at these levels is not compelling enough to buy.

The rally vs. the business

The stock has moved more than the fundamentals. From the $4.13 low, shares have climbed nearly 68% to the current price. That kind of move in a company reporting three consecutive years of declining revenue - fiscal 2024 down 3%, fiscal 2025 down 9%, fiscal 2026 down 4% to $5.0 billion - is not driven by earnings power. It is driven by sentiment that the restructuring plan, announced in May 2024, is finally working.

The problem is that the restructuring has not yet touched the top line. Revenue in the fourth quarter of fiscal 2026 (ended March 2026) fell 1% year-over-year to $1.2 billion. North America, which generates more than half of Under Armour's sales, declined 7%. Footwear, the category where Under Armour has lagged Nike and Deckers the most, fell 11% for the full fiscal year.

CEO Kevin Plank framed the Q4 result as progress: "topline stabilizes in fiscal 2027" and "operating model" improvements. That is the language of a company trying to convince investors that the trough is behind it. The market bought into enough of that message to push the stock up 38% this year.

But stabilization is not growth. And growth is what investors need to see before they stop pricing Under Armour as a distressed turnaround.

What the restructuring has actually delivered

Plank's four-pillar plan - product, story, service, and team - sounds coherent. The company is eliminating approximately 25% of its product lines, reducing promotional discounts, and shifting focus to higher-priced items in training, running, and team sports. The company previously announced plans to spend $500 million on marketing to rebuild brand heat. The restructuring costs are estimated at up to $160 million total; $147 million has already been recorded in restructuring and transformation charges.

On the cost side, there has been real movement. SG&A expenses fell 15% in the fourth quarter of fiscal 2026 to $518 million. Adjusted operating income turned positive at $3 million. The company raised its full-year fiscal 2026 adjusted EPS guidance from 3-5 cents to 10-11 cents.

That is progress. But it is also the easier part of the equation. Cutting costs and streamlining SKUs is something any shrinking business can do. Reversing the revenue decline, especially in North America where consumer share has slipped to Nike and fast-growing challengers like On and Hoka, is what actually determines whether Under Armour is a buy or a wait.

The cash and balance sheet reality

Here is where the picture gets uglier. Under Armour burned through $162 million in free cash flow over the trailing twelve months. Operating cash flow was negative $75 million. The company carries $3.0 billion in total debt, with net debt of $276 million after $309 million in cash. Return on invested capital is negative 18%.

The company also has $605 million in restricted investments set aside to repay its $600 million senior notes due in June 2026 (which were refinanced to 2030). Meanwhile, $200 million of borrowings are outstanding under the $1.1 billion revolving credit facility. The board approved a $500 million share buyback program in May 2024; $115 million of that has been executed so far, retiring 18 million shares.

None of that is a balance sheet crisis. The current ratio is 162% and the quick ratio is 108%, which means Under Armour can meet its near-term obligations. But a company that is negative on operating cash flow and burning $160 million annually in free cash flow is not in a position to fund an aggressive marketing rebuild without either raising prices, improving margins, or accepting further debt leverage.

Valuation: cheap, but for documented reasons

Under Armour trades at 0.6 times EV/sales, a negative P/E (the company is currently unprofitable on a GAAP basis), and 2.1 times book value. Compare that to Nike at 1.3 times sales and 19.9 times earnings, Deckers at 2.5 times sales and 13.5 times earnings, and VF Corp at 0.64 times sales and 22.1 times earnings.

The 0.6x EV/sales multiple looks cheap in a vacuum. But Under Armour is earning the discount. Three consecutive years of revenue decline, a negative operating margin of 3.3%, negative free cash flow, and a North American business that is still contracting - those are not temporary glitches. They are structural problems that require a multi-year fix.

VF Corp trades at a similar EV/sales multiple, but VF is profitable and pays a 2.3% dividend. Nike and Deckers command richer multiples because they are growing and generating cash. Under Armour sits below all three on operating performance and has no earnings power to anchor the valuation.

That means the stock is cheap, but the cheapness is a reflection of the operating picture, not a market inefficiency to exploit. The valuation only becomes a buying opportunity if the August 7 earnings and subsequent quarters show revenue stabilization and a credible path to positive operating cash flow.

The tariff overhang

Higher U.S. tariffs on imported goods are projected to add approximately $100 million to Under Armour's costs this fiscal year. Gross margin fell 250 basis points in Q2 fiscal 2026 and 470 basis points in Q4 fiscal 2026, with tariffs cited as a primary driver. The company's product is heavily manufactured overseas, and the margin impact is not fully priced into either the current quarter or the outlook.

Tariffs are a cost that Under Armour can partially offset through pricing, but in a market where the company is already struggling with share loss and promotional pressure, raising prices without demand to support them is a risky move. The tariff headwind is another reason to treat the "turnaround" thesis cautiously.

The catalyst clock

Under Armour reports fiscal 2027 first quarter results (period ended June 30, 2026) on August 7. The consensus calls for revenue around $1.22 billion and EPS of $0.023. The market expects the company to provide guidance for the full fiscal 2027 year.

That earnings report is the test. Here is what would change the rating:

• Upgrade to Buy case: Revenue stabilizes or grows year-over-year, especially in North America. Gross margin pressure eases. Management provides credible full-year 2027 guidance that projects revenue growth and positive free cash flow. The stock pulls back from current levels, bringing the EV/sales multiple closer to 0.5x.
• Hold case (current posture): Revenue continues to decline modestly (3-5%), margins improve through cost-cutting but not through demand, and guidance for fiscal 2027 is conservative. The stock holds around $6-$7.
• Downside risk: Revenue drops more than expected, North America accelerates its decline, tariffs bite harder than modeled, or management misses on adjusted EPS. The stock retests the $5 level.

The verdict

The "verge of a turnaround" narrative is the kind of framing that sounds right after a 68% climb from the lows but collapses under scrutiny. Under Armour has done the hard work of cutting costs, reducing product complexity, and raising restructuring spending transparency. Those are necessary steps.

But the business is still shrinking. It is still losing money. It is still bleeding free cash flow. And the stock has already moved 38% year-to-date, meaning much of the optimism about a turnaround is reflected in the current price.

The valuation is a floor, not a catalyst. At $6.91, there is room to the upside if the August 7 report delivers the stabilization investors hope for. But there is also plenty of room to the downside if the revenue declines continue and the market concludes that the restructuring has not solved the core problem - that Under Armour is losing share in North America faster than it can grow internationally.

Wait for the earnings report. The rating is Hold.